AI-identified molecules show an impressive 80-90% success rate in Phase I trials
Live Forever Club - 20-May-2024These early findings suggest AI could double the productivity of drug research
Join the club for FREE to access the whole archive and other member benefits.
Journal publishing research on all aspects of preclinical drug discovery.
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Visit website: https://www.journals.elsevier.com/drug-discovery-today
See also: Elsevier - Elsevier is a global information analytics business in science, health and technology
Details last updated 18-Dec-2020
These early findings suggest AI could double the productivity of drug research
Advances in longevity pharmacology to revolutionize healthcare with personalized therapies
Despite challenges, many companies and clinical trials in longevity field are constantly evolving